Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.52)
# 1,059
Out of 4,649 analysts
328
Total ratings
45.3%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics | Maintained: Buy | $8 | $1.92 | +316.67% | 12 | Aug 14, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $100 | $33.19 | +201.30% | 35 | Aug 14, 2026 | |
| EQ Equillium | Maintained: Buy | $10 | $2.36 | +323.73% | 2 | Aug 14, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $266 → $270 | $162.80 | +65.85% | 4 | Aug 14, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $7 | $5.44 | +28.68% | 8 | Aug 14, 2026 | |
| XNCR Xencor | Maintained: Buy | $44 | $23.34 | +88.52% | 5 | Aug 10, 2026 | |
| HROW Harrow | Maintained: Buy | $88 | $40.03 | +119.84% | 8 | Aug 10, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $15 | $3.61 | +315.51% | 4 | Aug 6, 2026 | |
| INVA Innoviva | Maintained: Buy | $32 → $34 | $21.19 | +60.45% | 6 | Aug 6, 2026 | |
| IFRX InflaRx | Maintained: Buy | $4 → $6 | $2.04 | +194.12% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $13.28 | +65.66% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $6.89 | +190.28% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $23.96 | +66.94% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $14.75 | +272.88% | 1 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $12 | $11.38 | +5.45% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $29 | $9.74 | +197.74% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $35.14 | +30.90% | 6 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 33.00 | kr 11.20 | +194.64% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $13 | $5.41 | +140.30% | 9 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.90 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | ¥272 | +315.44% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $26.98 | +81.62% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $228.65 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $15.15 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $103 | $138.36 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.82 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $17 | $5.57 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $51 | $115.96 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $56 | $25.70 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $77 | $100.64 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $0.644 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $3.47 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $78 | $11.91 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $117.39 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $507.56 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $5 | $0.1542 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $58.47 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $8.23 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.5231 | n/a | 10 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $6.68 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $209.83 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $53.55 | n/a | 12 | Jun 13, 2021 |
ProQR Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.92
Upside: +316.67%
Viking Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $100
Current: $33.19
Upside: +201.30%
Equillium
Aug 14, 2026
Maintained: Buy
Price Target: $10
Current: $2.36
Upside: +323.73%
Belite Bio
Aug 14, 2026
Maintained: Buy
Price Target: $266 → $270
Current: $162.80
Upside: +65.85%
Camp4 Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $7
Current: $5.44
Upside: +28.68%
Xencor
Aug 10, 2026
Maintained: Buy
Price Target: $44
Current: $23.34
Upside: +88.52%
Harrow
Aug 10, 2026
Maintained: Buy
Price Target: $88
Current: $40.03
Upside: +119.84%
Opus Genetics
Aug 6, 2026
Maintained: Buy
Price Target: $15
Current: $3.61
Upside: +315.51%
Innoviva
Aug 6, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $21.19
Upside: +60.45%
InflaRx
Aug 6, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $2.04
Upside: +194.12%
Aug 6, 2026
Maintained: Buy
Price Target: $22
Current: $13.28
Upside: +65.66%
Aug 6, 2026
Maintained: Buy
Price Target: $20
Current: $6.89
Upside: +190.28%
Aug 6, 2026
Maintained: Buy
Price Target: $40
Current: $23.96
Upside: +66.94%
Aug 5, 2026
Maintained: Buy
Price Target: $55
Current: $14.75
Upside: +272.88%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $11.38
Upside: +5.45%
Jun 30, 2026
Maintained: Buy
Price Target: $26 → $29
Current: $9.74
Upside: +197.74%
Jun 29, 2026
Maintained: Buy
Price Target: $46
Current: $35.14
Upside: +30.90%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: kr 11.20
Upside: +194.64%
May 18, 2026
Maintained: Buy
Price Target: $34 → $13
Current: $5.41
Upside: +140.30%
Apr 1, 2026
Maintained: Hold
Price Target: n/a
Current: $1.90
Upside: -
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: ¥272
Upside: +315.44%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $26.98
Upside: +81.62%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $228.65
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $22
Current: $15.15
Upside: n/a
Nov 8, 2024
Maintained: Buy
Price Target: $93 → $103
Current: $138.36
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.82
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $22 → $17
Current: $5.57
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $24 → $51
Current: $115.96
Upside: n/a
Jan 3, 2024
Maintained: Buy
Price Target: $27 → $56
Current: $25.70
Upside: n/a
Oct 18, 2023
Maintained: Buy
Price Target: $84 → $77
Current: $100.64
Upside: n/a
Jun 23, 2023
Maintained: Buy
Price Target: $25 → $17
Current: $0.644
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $33 → $35
Current: $3.47
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $94 → $78
Current: $11.91
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $117.39
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $507.56
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $15 → $5
Current: $0.1542
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $38
Current: $58.47
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $8.23
Upside: n/a
May 18, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.5231
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $18
Current: $6.68
Upside: n/a
Jul 22, 2021
Maintained: Hold
Price Target: n/a
Current: $209.83
Upside: n/a
Jun 13, 2021
Maintained: Sell
Price Target: n/a
Current: $53.55
Upside: n/a